Based on the filings with the Hong Kong Stock Exchange, Maiwei (Shanghai) Biotechnology Co., Ltd.-B has officially submitted its application for listing. The company has appointed Haitong International and CITIC Securities to act as its joint sponsors for this significant financial move.